Predicting safe drug candidates with Bio-AI
Quris AI (quris.ai) earns a Brand Analyzer score of 69 out of 100, placing it in the Developing tier among Healthcare brands, Technology brands. Among 2305 Healthcare brands analyzed, Quris AI ranks in the 56th percentile (category average 68, leader 95). The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark. Dimension scores: Name Quality 100/100, Digital Presence 82/100, Visual Identity 90/100, Messaging Clarity 100/100, Trust Foundation 62/100, AI Discoverability 81/100, Brand Authority 11/100.
Quris AI is a healthcare technology company that applies machine learning to predict which drug candidates will safely work in humans. Its platform combines AI with miniaturized Patients-on-a-Chip technology to generate data for drug safety predictions. The company targets pharmaceutical companies and drug developers, positioning itself as the first AI safety prediction platform designed to address high clinical trial failure rates-a challenge it argues other AI-pharma companies overlook.
| Brand Name | Quris AI |
|---|---|
| Domain | quris.ai |
| Industry | Healthcare, Technology |
| Main Competitors | Insilico Medicine, Recursion Pharmaceuticals, Schrödinger (87/100), Exscientia, BenevolentAI, Atomwise |
Moz Domain Authority 31/100 vs category average 29 / leader 95 - a strong backlink profile, so AI systems frequently encounter mentions of the brand.
No Wikipedia presence was found - a major gap, since Wikipedia is among the most heavily weighted sources in AI training data.
The homepage meta description reads "Quris AI is tackling the most impactful AI challenge of our time: Predicting which drug candidates will safely work in humans. Quris’s machine-learning bio-platform predicts which …" (Meta description: 33 words. OG description present and descriptive) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: 3 JSON-LD block(s), Organization schema, Breadcrumb/Website schema, og:title, og:description, og:image, og:type, Twitter cards, canonical. Adding FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Social footprint: verified profiles on LinkedIn, Instagram, YouTube, GitHub; no detected presence on X (Twitter), Facebook - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Quris AI scores 35/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
Quris AI has a weak AI-visibility profile at 35/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is recommendation likelihood (50/100) and its weakest is visibility (17/100). It benefits from a Wikidata knowledge-graph entry, open access for AI crawlers (GPTBot, ClaudeBot, etc.) and machine-readable schema.org markup. The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data and a low Moz Domain Authority of 31/100.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
Quris AI's main competitors include Insilico Medicine, Recursion Pharmaceuticals, Schrödinger, Exscientia, BenevolentAI. These companies compete in the Healthcare space for similar customers, offering comparable products or services.
Sources: Quris AI official site
Popular alternatives to Quris AI include Insilico Medicine, Recursion Pharmaceuticals, Schrödinger, Exscientia, BenevolentAI. Each is an established option in the Healthcare space; the best fit depends on your specific needs, budget, and required features.
Sources: Quris AI official site
Quris AI has limited AI-search visibility, scoring 35/100 on Brand Analyzer's AI visibility composite (visibility 17, trust 49, recommendation 50). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: Quris AI official site
Quris AI uses a machine-learning bio-platform to predict which drug candidates will safely work in humans. It combines AI algorithms with miniaturized Patients-on-a-Chip technology to generate data for accurate drug safety predictions. The company specifically targets the high failure rate in clinical trials, arguing that this safety-prediction gap is a challenge that other AI-pharma companies overlook. Its goal is to help pharmaceutical companies and drug developers identify viable candidates earlier in the development process.
Sources: Quris AI official site
Quris AI is a healthcare technology company that operates a machine-learning bio-platform focused on drug safety prediction. It describes itself as 'Pharma's first AI safety prediction platform' and positions its work as tackling one of the most impactful AI challenges in medicine: predicting which drug candidates will safely work in humans. The company combines artificial intelligence with miniaturized Patients-on-a-Chip technology to generate data intended to improve the accuracy of drug safety assessments before clinical trials.
Sources: Quris AI official site
Quris AI and Insilico Medicine are competitors in Healthcare. They target overlapping audiences; the right choice depends on your specific needs and priorities.
Sources: Quris AI official site
Quris AI scores 50/100 on Brand Analyzer's AI recommendation signal, indicating it is reasonably likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority.
Sources: Quris AI official site
Based on available information, Quris AI offers a machine-learning bio-platform that predicts drug candidate safety in humans. A key component of this platform is the integration of miniaturized Patients-on-a-Chip technology, which is used to generate biological data that feeds into the AI's safety predictions. The platform is positioned as a service for pharmaceutical companies and drug developers seeking to reduce clinical trial failure rates. No additional distinct product names or service tiers are specified in the available facts.
Sources: Quris AI official site
Quris AI can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: Quris AI official site
Quris AI's stated target audience is pharmaceutical companies and drug developers. These are organizations engaged in the drug development process that seek to reduce the high rate of clinical trial failures, particularly those related to drug safety. By predicting which candidates will safely work in humans prior to or during clinical development, Quris AI aims to serve companies looking to improve the efficiency and success rate of their drug pipelines.
Sources: Quris AI official site
Quris AI is known for its AI-driven drug safety prediction platform, which it describes as the first of its kind in the pharmaceutical industry. It is particularly noted for combining machine learning with miniaturized Patients-on-a-Chip technology to predict whether drug candidates will be safe in humans. The company frames its approach as addressing a trillion-dollar drug development challenge-the high rate of clinical trial failures-that it contends other AI-pharma companies have not adequately addressed.
Sources: Quris AI official site
Ranked closest to Quris AI: Psychē Systems (69/100), Prolaio (69/100), RedBrick AI (69/100), RISA Labs (69/100).
A step up - brands to learn from: Zipari by mPulse (71/100), Zaina AI (71/100).
Category leader: Dassault Systèmes (95/100).